Insider Selling: ConvaTec Group PLC (LON:CTEC) Insider Sells 132,253 Shares of Stock

ConvaTec Group PLC (LON:CTEC) insider Karim Bitar sold 132,253 shares of the business’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.33), for a total transaction of £338,567.68 ($439,755.40).

Karim Bitar also recently made the following trade(s):

• On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.33), for a total transaction of £1,117,931.52 ($1,452,047.69).

ConvaTec Group Stock Up 0.5 %

Shares of CTEC traded up GBX 1.40 ($0.02) during mid-day trading on Tuesday, hitting GBX 259.40 ($3.37). 373,079,156 shares of the company traded hands, compared to its average volume of 27,658,520. ConvaTec Group PLC has a 1-year low of GBX 211.80 ($2.75) and a 1-year high of GBX 295.20 ($3.83). The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The company has a market capitalization of £6.60 billion, a PE ratio of 43.68, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. The business has a 50 day moving average of GBX 245.67 and a 200 day moving average of GBX 234.36.

ConvaTec Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, April 17th will be issued a dividend of $0.05 per share. The ex-dividend date is Thursday, April 17th. This represents a dividend yield of 1.36%. This is an increase from ConvaTec Group’s previous dividend of $0.02. ConvaTec Group’s dividend payout ratio is 84.20%.

Analyst Ratings Changes

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 310 ($4.03) target price on shares of ConvaTec Group in a report on Wednesday, March 5th.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.